ProShare Advisors LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 151 filers reported holding FATE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.4%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$36,998
-55.3%
17,452
+0.4%
0.00%
Q2 2023$82,771
-12.5%
17,389
+4.8%
0.00%
Q1 2023$94,557
-53.1%
16,589
-17.0%
0.00%
-100.0%
Q4 2022$201,628
-51.8%
19,983
+7.2%
0.00%
-50.0%
Q3 2022$418,000
-7.1%
18,636
+2.3%
0.00%
+100.0%
Q2 2022$450,000
-57.1%
18,209
-32.7%
0.00%
-50.0%
Q1 2022$1,049,000
-46.0%
27,053
-18.5%
0.00%
-50.0%
Q4 2021$1,943,000
+0.4%
33,208
+1.7%
0.00%
-20.0%
Q3 2021$1,935,000
-40.8%
32,646
-13.3%
0.01%
-50.0%
Q2 2021$3,269,000
+19.0%
37,662
+13.1%
0.01%
+11.1%
Q1 2021$2,746,000
+3.0%
33,302
+13.5%
0.01%
-10.0%
Q4 2020$2,667,000
+193.1%
29,333
+28.8%
0.01%
+150.0%
Q3 2020$910,000
+26.7%
22,774
+8.8%
0.00%0.0%
Q2 2020$718,000
+131.6%
20,928
+50.0%
0.00%
+100.0%
Q1 2020$310,000
-35.6%
13,954
-43.2%
0.00%0.0%
Q4 2019$481,000
+31.1%
24,569
+4.0%
0.00%0.0%
Q3 2019$367,000
-29.0%
23,627
-7.2%
0.00%
-33.3%
Q2 2019$517,000
+3.2%
25,449
-10.7%
0.00%0.0%
Q1 2019$501,000
+38.0%
28,513
+0.9%
0.00%0.0%
Q4 2018$363,00028,2700.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 716,392$11,126,00012.18%
Polaris Venture Management Co. V, L.L.C. 1,139,783$17,701,00010.06%
Grosvenor Holdings, L.L.C. 2,285,714$35,497,0006.41%
Redmile Group, LLC 11,216,809$174,197,0005.83%
Casdin Capital, LLC 2,550,000$39,601,500,0004.10%
DAFNA Capital Management LLC 470,000$7,299,0002.74%
Ghost Tree Capital, LLC 350,000$5,436,0001.38%
Artal Group S.A. 2,000,000$31,060,0001.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,952,897$30,328,0001.24%
Copernicus Capital Management, LLC 75,000$1,165,0001.08%
View complete list of FATE THERAPEUTICS INC shareholders